S&P 5007,675.92▼0.4% Nasdaq26,749.30▼0.7% Dow51,245.74▼0.5% Russell 2K2,826.40▼0.4% 10-Yr5.12%+1bp VIX15.69+0.51 WTI$95.27▲3.4% Gold$4,292.50▼0.6% EUR/USD1.138▼0.6% BTC$84,310▼0.1% Nikkei65,514▲0.8%
At close · Thu, Sep 24, 2026
Daily Market Updates.

US Markets

Home›US Markets›M&A & Deals›AstraZeneca and Bristol-Myers Squibb tie-up talks roil…

AstraZeneca and Bristol-Myers Squibb tie-up talks roil shares

Bristol-Myers Squibb stock rose while AstraZeneca shares fell as reports of potential deal discussions spread.

Reported · Written up by our desk · M&A & Deals

MarketWatch reports that shares of AstraZeneca and Bristol-Myers Squibb moved sharply on Monday amid reports of tie-up talks.

According to MarketWatch, Bristol-Myers Squibb was jumping while AstraZeneca was slumping.

The report notes analysts are focused on the rationale for a potential combination between the two pharmaceutical companies, beyond the immediate stock reaction.

← Newer storyBithumb lays out roadmap for 2028 IPO after K-IFRS shift

More like this

US MarketsKFC opens a new Texas restaurant concept to test customer service
US MarketsSony, A24 and The New York Times Company register interest in Letterboxd
US MarketsNew York sues Polymarket U.S. over alleged gambling law violations
US MarketsMay Mobility to go public via SPAC merger valued near $1.4 billion
US MarketsSK Hynix weighs US memory chip plans with Intel’s Ohio site

Sources

MarketWatchAstraZeneca reported tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.
MarketWatchAstraZeneca reported tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.